Jun-Li Cao Selected Research

U 0126 (UO 126)

1/2018	Inhibition of spinal MAPKs by scorpion venom peptide BmK AGAP produces a sensory-specific analgesic effect.
2/2007	[Effects of intrathecal injection of U0126 on the expression of phospho-CREB in spinal cord of morphine-induced withdrawal rats].
12/2005	Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats.
10/2005	[Activation of the spinal extracellular signal-regulated kinase is involved in morphine dependence and naloxone-precipitated withdrawal response].
7/2005	Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats.
4/2005	[cAMP response-element binding protein participates in the phosphorylated extracellular signal-regulate kinase mediated neuropathic pain].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun-Li Cao Research Topics

Disease

26	Pain (Aches) 01/2022 - 01/2006
19	Hyperalgesia 03/2020 - 04/2005
16	Neuralgia (Stump Neuralgia) 01/2022 - 04/2005
8	Inflammation (Inflammations) 01/2019 - 04/2005
8	Substance Withdrawal Syndrome (Withdrawal Symptoms) 04/2011 - 10/2003
5	Morphine Dependence 05/2021 - 08/2002
5	Hypersensitivity (Allergy) 01/2021 - 09/2008
3	Ischemia 01/2022 - 07/2005
3	Chronic Pain 10/2020 - 07/2014
2	Emergence Delirium 01/2022 - 12/2016
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2022
2	Cognitive Dysfunction 11/2021 - 07/2012
2	Cerebral Infarction 01/2019 - 01/2019
2	Intracranial Vasospasm 01/2019 - 01/2019
2	Postoperative Pain 01/2019 - 05/2014
2	Peripheral Nerve Injuries 08/2014 - 11/2008
2	Acute Pain 05/2014 - 01/2011
2	Sciatica (Sciatic Neuralgia) 10/2005 - 04/2005
1	Neoplasms (Cancer) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Pulmonary Atelectasis 01/2022
1	Anxiety Disorders (Anxiety Disorder) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 05/2021
1	Constipation 05/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Hallucinations (Hallucination) 12/2019
1	Bradycardia 12/2019
1	Hypotension (Low Blood Pressure) 12/2019
1	Postoperative Cognitive Complications 01/2019
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2019
1	Aneurysm (Aneurysms) 01/2019

Drug/Important Bio-Agent (IBA)

13	Morphine (MS Contin)FDA LinkGeneric 05/2021 - 08/2002
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2005
6	U 0126 (UO 126)IBA 01/2018 - 04/2005
6	Formaldehyde (Formol)FDA Link 01/2018 - 10/2008
6	Naloxone (Narcan)FDA LinkGeneric 05/2014 - 08/2002
4	Messenger RNA (mRNA)IBA 01/2022 - 08/2014
4	Freund's AdjuvantIBA 01/2022 - 07/2014
4	Opioid Analgesics (Opioids)IBA 05/2021 - 05/2014
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 12/2005
4	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 04/2011 - 04/2005
3	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2014
3	Ketamine FDA LinkGeneric 10/2020 - 05/2014
3	Dexmedetomidine FDA Link 01/2019 - 12/2016
3	Proto-Oncogene Proteins c-fos (FRAs)IBA 01/2018 - 05/2010
2	DioxygenasesIBA 01/2021 - 01/2017
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2020 - 10/2017
2	CytokinesIBA 03/2020 - 01/2016
2	LithiumIBA 01/2020 - 06/2011
2	Corticotropin-Releasing HormoneIBA 01/2020 - 01/2016
2	Therapeutic UsesIBA 01/2020 - 06/2011
2	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 04/2005
2	Nimodipine (Modus)FDA LinkGeneric 01/2019 - 01/2019
2	Sufentanil (Sufenta)FDA LinkGeneric 01/2019 - 01/2019
2	SB 203580IBA 01/2018 - 10/2005
2	Analgesics (Analgesic Drugs)IBA 08/2014 - 05/2014
2	Mitogen-Activated Protein KinasesIBA 04/2011 - 10/2008
2	Dizocilpine Maleate (Dizocilpine)IBA 05/2010 - 12/2005
2	Eph Family Receptors (Eph Receptors)IBA 11/2008 - 09/2008
2	Phosphotransferases (Kinase)IBA 09/2008 - 04/2005
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2007 - 12/2005
2	Antisense OligonucleotidesIBA 12/2005 - 02/2004
2	Protein Kinase CIBA 12/2005 - 04/2005
2	Silk FDA Link 10/2005 - 04/2005
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2005 - 07/2005
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022
1	ZincIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	AlbuminsIBA 01/2022
1	CreatinineIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2021
1	HomocysteineIBA 11/2021
1	neuropeptide BIBA 05/2021
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 05/2021
1	Pharmaceutical PreparationsIBA 05/2021
1	NeuropeptidesIBA 05/2021
1	human NPW proteinIBA 05/2021
1	Sucrose (Saccharose)IBA 01/2021
1	6-methyladenineIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	EnzymesIBA 03/2020
1	ImmunosorbentsIBA 03/2020
1	MuscimolIBA 01/2020
1	Circular RNAIBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	CalciumIBA 01/2019
1	Narcotics (Narcotic Analgesics)IBA 01/2019
1	FilaminsIBA 01/2019
1	urapidilIBA 01/2019
1	Sodium Chloride FDA LinkGeneric 01/2019
1	pyrazolanthroneIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	fluorocitrateIBA 01/2017

Therapy/Procedure

8	Spinal Injections 01/2018 - 02/2004
3	Analgesia 03/2016 - 05/2014
1	Therapeutics 01/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022
1	Anesthesia 01/2019